7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 
      
    		                                       
      assets
    		                                       
      investment in real estate:
    		                                       
      land
    		171,349,000 173,123,000 173,293,000 174,300,000 168,110,000 162,391,000 164,315,000 164,315,000 164,315,000 165,242,000 167,285,000 168,308,000 168,289,000 165,045,000 155,529,000 152,060,000 149,249,000 145,424,000 133,040,000 128,857,000 116,123,000 104,316,000 101,715,000 95,381,000 86,878,000 76,831,000 68,326,000 63,710,000 56,839,000 55,330,000 52,301,000 42,701,000 36,839,127 25,822,453 23,130,337 17,785,001 11,733,852 7,043,852 7,043,852 
      building
    		1,087,622,000 1,095,324,000 1,064,782,000 1,044,019,000 1,041,006,000 1,028,539,000 1,036,224,000 1,035,705,000 1,034,822,000 1,038,464,000 1,077,340,000 1,079,781,000 1,079,380,000 1,049,876,000 1,002,087,000 985,091,000 964,169,000 931,510,000 883,901,000 851,427,000 793,559,000 755,807,000 745,649,000 693,533,000 637,505,000 597,029,000 533,430,000 518,451,000 493,503,000 486,766,000 436,185,000 384,338,000 349,041,480 306,198,609 270,401,823 179,253,398    
      site improvements
    		25,065,000 24,966,000 24,266,000 23,973,000 22,946,000 21,960,000 21,984,000 21,974,000 21,480,000 21,404,000 22,024,000 22,024,000 21,983,000 20,805,000 19,596,000 19,021,000 18,017,000 17,011,000 15,669,000 15,183,000 13,268,000 11,593,000 11,303,000 9,912,000 9,100,000 7,672,000 6,982,000 6,880,000 6,714,000 6,562,000 5,590,000 4,808,000 3,992,974 3,115,289 2,686,216 1,465,273    
      tenant improvements
    		79,979,000 80,019,000 75,023,000 69,679,000 66,933,000 66,004,000 67,021,000 66,358,000 65,772,000 66,544,000 66,375,000 65,987,000 65,004,000 62,500,000 60,154,000 58,900,000 56,156,000 53,730,000 50,596,000 49,204,000 46,965,000 41,891,000 37,044,000 33,909,000 31,465,000 27,371,000 16,206,000 15,357,000 14,328,000 12,189,000 9,201,000 8,010,000 5,095,651 2,996,662 2,552,449 1,186,014    
      acquired lease intangible assets
    		144,696,000 147,376,000 141,828,000 138,945,000 137,886,000 136,394,000 138,617,000 138,617,000 138,617,000 139,715,000 148,249,000 148,077,000 147,836,000 146,339,000 130,790,000 127,931,000 123,918,000 112,649,000 103,269,000 98,234,000 91,465,000 83,269,000 78,977,000 72,794,000 65,498,000 54,698,000 43,987,000 43,152,000 41,653,000 41,162,000 34,034,000 31,650,000 27,308,632 17,218,214 15,991,981 7,144,276    
      ​
    		1,508,711,000 1,520,808,000 1,479,192,000 1,450,916,000 1,436,881,000 1,415,288,000 1,428,161,000 1,426,969,000 1,425,006,000 1,431,369,000 1,481,273,000 1,484,177,000 1,482,492,000 1,444,565,000 1,368,156,000 1,343,003,000 1,311,509,000 1,260,324,000 1,186,475,000 1,142,905,000 1,061,380,000 996,876,000                  
      less: accumulated depreciation and amortization
    		-327,248,000 -316,649,000 -301,190,000 -288,921,000 -283,941,000 -271,764,000 -262,287,000 -247,503,000 -232,518,000 -218,109,000 -213,690,000 -198,218,000 -182,255,000 -172,006,000 -157,132,000 -143,255,000 -130,284,000 -117,720,000 -105,779,000 -94,462,000 -83,893,000 -73,979,000 -64,635,000 -56,503,000 -48,731,000 -41,882,000 -35,771,000 -30,625,000 -26,839,000 -22,026,000 -17,420,000 -13,594,000 -10,142,823       
      investment in real estate
    		1,181,463,000 1,204,159,000 1,178,002,000 1,161,995,000 1,152,940,000 1,143,524,000 1,165,874,000 1,179,466,000 1,192,488,000 1,213,260,000 1,267,583,000 1,285,959,000 1,300,237,000 1,272,559,000 1,211,024,000 1,199,748,000 1,181,225,000 1,142,604,000 1,080,696,000 1,048,443,000 977,487,000 922,897,000 910,053,000 849,026,000 781,715,000 721,719,000 633,160,000 616,925,000 586,198,000 579,983,000 519,891,000 457,913,000 412,135,041 331,612,458 294,100,857 196,365,771 122,311,086 92,152,179 92,696,181 
      cash and cash equivalents
    		7,123,000 6,580,000 5,412,000 6,815,000 5,723,000 4,978,000 1,333,000 1,278,000 1,281,000 2,460,000 4,603,000 4,016,000 3,199,000 5,873,000 1,854,000 7,213,000 6,030,000 5,821,000 5,304,000 5,507,000 2,052,000 8,392,000 11,340,000 2,765,000 2,815,000 3,216,000 1,844,000 3,631,000 3,005,000 4,755,000 3,351,000 5,109,000        
      restricted cash
    		2,717,000 2,646,000 2,176,000 2,127,000 2,066,000 2,840,000 6,473,000 5,446,000 6,331,000 7,325,000 9,378,000 10,439,000 10,396,000 8,327,000 6,336,000 5,546,000 5,839,000 6,549,000 6,096,000 5,246,000 5,210,000 4,945,000 5,536,000 4,420,000 3,011,000 2,656,000 1,464,000 1,212,000 817,000 1,432,000 4,050,000 2,005,000 2,040,026 2,291,080 1,773,909 941,344 805,776 977,578 1,277,831 
      tenant receivables
    		7,945,000 7,826,000 8,104,000 7,424,000 8,122,000 8,073,000 7,743,000 6,762,000 7,527,000 7,381,000 7,402,000 8,040,000 6,382,000 6,189,000 6,477,000 6,070,000 5,126,000 4,886,000 5,585,000 5,596,000 6,702,000 5,888,000 5,708,000 4,957,000 4,167,000 3,935,000 3,559,000 2,905,000 1,744,000 1,339,000 1,253,000 704,000 616,741 534,484 347,110 212,435 177,369  261,955 
      due from related parties
    		367,000 461,000 420,000 270,000 404,000 410,000 363,000 193,000 289,000 391,000 321,000 200,000 337,000 337,000 451,000 163,000 275,000 265,000 229,000 103,000 121,000 124,000 70,000 50,000 75,000               
      escrow deposits
    		552,000 556,000 915,000 711,000 1,694,000 925,000 737,000 673,000 9,861,000 9,725,000 8,625,000 7,833,000 7,660,000 7,708,000 7,697,000 5,957,000 5,970,000 5,531,000 5,163,000 4,817,000 3,792,000 3,301,000 3,589,000 3,417,000 2,865,000 3,518,000 3,296,000 1,752,000 2,628,000 2,080,000 2,508,000 1,638,000 1,297,665 979,709 2,528,996 1,212,177 903,636 945,162 889,519 
      deferred assets
    		29,205,000 28,672,000 28,251,000 28,208,000 27,685,000 28,360,000 27,995,000 27,132,000 26,748,000 26,189,000 30,322,000 29,616,000 28,667,000 27,731,000 26,714,000 25,417,000 24,422,000 23,050,000 21,676,000 20,272,000 18,928,000 17,433,000 16,141,000 14,512,000 13,307,000 11,831,000 10,358,000 9,352,000 8,590,000 7,200,000 5,171,000 3,993,000 2,923,494 1,867,010 1,087,148 704,537 245,619 1,735,973 436,068 
      derivative asset
    		7,467,000 10,396,000 13,713,000 18,613,000 14,967,000 27,672,000 29,285,000 25,125,000 38,379,000 35,864,000 27,428,000 34,705,000 36,926,000 16,583,000 12,692,000 1,236,000 219,000 137,000 136,000     2,194,000                
      goodwill
    		5,903,000 5,903,000 5,903,000 5,903,000 5,903,000 5,903,000 5,903,000 5,903,000 5,903,000 5,903,000 5,903,000 5,903,000 5,903,000 5,903,000 5,903,000 5,903,000 5,903,000 5,903,000 5,903,000 5,903,000 5,903,000                   
      investment in unconsolidated joint venture
    		1,846,000 1,917,000 1,992,000 2,066,000                                    
      other assets
    		28,650,000 27,843,000 24,667,000 22,354,000 23,091,000 18,530,000 17,874,000 15,722,000 13,713,000 12,302,000 7,473,000 6,550,000 7,042,000 6,056,000 6,345,000 6,232,000 8,297,000 5,219,000 5,530,000 5,019,000 5,356,000 3,587,000 3,731,000 3,593,000 4,363,000 3,847,000 3,009,000 322,000 1,109,000 2,283,000 527,000 459,000 160,214 88,695 11,484 140,374    
      total assets
    		1,273,238,000 1,296,959,000 1,269,555,000 1,256,486,000 1,242,595,000 1,241,215,000 1,263,580,000 1,267,700,000 1,302,520,000 1,320,800,000 1,369,038,000 1,393,261,000 1,406,749,000 1,357,266,000 1,285,493,000 1,263,485,000 1,243,306,000 1,199,965,000 1,136,318,000 1,100,906,000 1,025,551,000 966,567,000 956,168,000 884,934,000 812,318,000 750,722,000 656,690,000 636,099,000 604,091,000 602,027,000 539,856,000 474,571,000 428,927,663 369,395,591 325,768,465 227,319,130 205,791,478 98,385,696 96,096,760 
      liabilities and equity
    		                                       
      liabilities:
    		                                       
      credit facility, net of unamortized debt issuance costs of 3,218 and 4,868 at september 30, 2025 and december 31, 2024, respectively
    		708,482,000                                       
      notes payable, net of unamortized debt issuance costs of 22 at december 31, 2024
    		1,153,000                                       
      accounts payable and accrued expenses
    		17,808,000 19,006,000 14,519,000 16,468,000 13,350,000 11,962,000 10,520,000 12,781,000 13,300,000 15,457,000 12,604,000 13,819,000 13,100,000 11,922,000 9,272,000 10,344,000 11,065,000 8,080,000 7,230,000 7,279,000 8,329,000 8,836,000 7,144,000 5,069,000 5,501,000 4,224,000 3,385,000 3,664,000 4,420,000 5,494,000 4,125,000 2,020,000 2,433,549 2,216,953 1,932,590 573,997    
      dividends payable
    		12,051,000 11,985,000 16,597,000 16,520,000 16,534,000 16,280,000 16,157,000 16,134,000 16,055,000 16,048,000 15,854,000 15,821,000 15,777,000 15,926,000 15,823,000 15,668,000 15,309,000 15,251,000 14,482,000 12,470,000 11,843,000 11,281,000 10,949,000 11,091,000 9,470,000 9,081,000 8,985,000 6,981,000 6,109,000 5,940,000 5,826,000 5,638,000 4,767,037 3,700,936 3,651,817 3,604,037 3,592,786   
      security deposits
    		3,512,000 3,407,000 3,374,000 3,324,000 3,222,000 3,973,000 4,376,000 3,688,000 3,913,000 4,213,000 4,688,000 5,461,000 5,404,000 5,304,000 4,616,000 4,540,000 4,600,000 4,385,000 4,367,000                2,099,844 719,592 597,593 319,499 319,499 
      other liabilities
    		18,888,000 18,438,000 16,030,000 14,191,000 12,370,000 12,809,000 12,952,000 12,770,000 12,138,000 12,137,000 8,226,000 7,363,000 6,848,000 7,428,000 7,090,000 7,709,000 7,104,000 5,983,000 6,793,000 6,171,000                    
      acquired lease intangible liability
    		5,516,000 6,117,000 3,902,000 3,936,000 3,638,000 4,149,000 4,713,000 5,281,000 5,860,000 6,444,000 7,028,000 7,613,000 8,220,000 7,903,000 8,161,000 8,128,000 8,333,000 8,437,000 7,998,000 8,222,000 8,621,000 5,598,000 3,425,000 3,164,000 3,287,000 2,778,000 2,004,000 2,028,000 2,034,000 2,081,000 1,488,000 1,291,000 1,080,123 1,112,566 475,343 277,917    
      total liabilities
    		767,410,000 771,938,000 731,452,000 700,570,000 677,989,000 662,843,000 666,482,000 661,886,000 668,872,000 679,408,000 740,563,000 744,196,000 742,165,000 708,157,000 632,876,000 625,908,000 613,081,000 562,710,000 540,499,000 643,146,000 576,344,000 523,858,000 517,378,000 424,581,000 440,875,000 389,119,000 286,128,000 336,349,000 349,435,000 346,514,000 285,113,000 215,558,000 175,900,856 193,092,997 176,513,596 72,290,752 46,083,186 86,250,769 83,346,083 
      commitments and contingencies
    		                                       
      equity:
    		                                       
      preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at september 30, 2025 and december 31, 2024, respectively
    		74,959,000                                       
      common stock
    		13,000 67,000 67,000 67,000 67,000 66,000 66,000 66,000 66,000 66,000 66,000 66,000 66,000 66,000 65,000 65,000 64,000 64,000 61,000 49,000 48,000 46,000 44,000 44,000 36,000 35,000 35,000 26,000 22,000 22,000 22,000 22,000 21,631       
      additional paid-in capital
    		735,416,000 734,290,000 734,290,000 734,223,000 733,626,000 722,627,000 722,623,000 722,418,000 722,418,000 722,418,000 722,113,000 721,991,000 722,074,000 722,074,000 720,306,000 711,414,000 700,206,000 700,038,000 648,949,000 504,789,000 487,114,000 462,607,000 440,220,000 433,330,000 340,435,000 322,872,000 322,359,000 243,038,000 208,938,000 205,788,000 205,788,000 205,788,000 207,268,720 202,513,240 172,417,006 171,997,396 171,143,411 18,010,613 18,010,613 
      accumulated deficit
    		-332,566,000 -316,510,000 -305,677,000 -293,736,000 -281,067,000 -268,885,000 -251,963,000 -238,984,000 -224,375,000 -213,744,000 -211,794,000 -198,706,000 -185,316,000 -179,614,000 -168,089,000 -157,017,000 -147,562,000 -138,088,000 -127,480,000 -116,773,000 -107,943,000 -88,037,000 -78,990,000 -71,389,000 -63,846,000 -57,397,000 -51,390,000 -45,007,000 -46,855,000 -42,739,000 -38,349,000 -34,434,000 -29,914,472 -26,231,752 -23,179,743 -16,986,624 -11,452,725 -5,877,113 -5,261,363 
      accumulated other comprehensive income
    		7,467,000 10,396,000 13,713,000 18,613,000 14,967,000 27,672,000 29,285,000 25,125,000 38,379,000 35,859,000 27,410,000 34,674,000 36,883,000 16,527,000 10,757,000                         
      total global medical reit inc. stockholders' equity
    		485,289,000 503,202,000 517,352,000 534,126,000 542,552,000 556,439,000 574,970,000 583,584,000 611,447,000 619,558,000 612,754,000 632,984,000 648,666,000 634,012,000 637,998,000 622,785,000 615,721,000 623,189,000 581,901,000 444,805,000 434,527,000  415,601,000 430,270,000 340,988,000 331,176,000  269,295,000 236,955,000 238,030,000 242,420,000 246,335,000 252,334,882       
      noncontrolling interest
    		20,539,000 21,819,000 20,751,000 21,790,000 22,054,000 21,933,000 22,128,000 22,230,000 22,201,000 21,834,000 15,721,000 16,081,000 15,918,000 15,097,000 14,619,000 14,792,000 14,504,000 14,066,000 13,918,000 12,955,000 14,680,000 14,788,000 23,189,000 30,083,000 30,455,000 30,427,000 30,342,000 30,455,000 17,701,000 17,483,000 12,323,000 12,678,000 691,925       
      total equity
    		505,828,000 525,021,000 538,103,000 555,916,000 564,606,000 578,372,000 597,098,000 605,814,000 633,648,000 641,392,000 628,475,000 649,065,000 664,584,000 649,109,000 652,617,000 637,577,000 630,225,000 637,255,000 595,819,000 457,760,000 449,207,000 442,709,000 438,790,000 460,353,000 371,443,000 361,603,000      259,013,000 253,026,807       
      total liabilities and equity
    		1,273,238,000 1,296,959,000 1,269,555,000 1,256,486,000 1,242,595,000 1,241,215,000 1,263,580,000 1,267,700,000 1,302,520,000 1,320,800,000 1,369,038,000 1,393,261,000 1,406,749,000 1,357,266,000 1,285,493,000 1,263,485,000 1,243,306,000 1,199,965,000 1,136,318,000 1,100,906,000 1,025,551,000 966,567,000 956,168,000 884,934,000 812,318,000 750,722,000              
      credit facility, net of unamortized debt issuance costs of 3,768 and 4,868 at june 30, 2025 and december 31, 2024, respectively
    		 698,832,000                                      
      notes payable, net of unamortized debt issuance costs of 4 and 22 at june 30, 2025 and december 31, 2024, respectively
    		 14,153,000                                      
      preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at june 30, 2025 and december 31, 2024, respectively
    		 74,959,000                                      
      credit facility, net of unamortized debt issuance costs of 4,318 and 4,868 at march 31, 2025 and december 31, 2024, respectively
    		  662,782,000                                     
      notes payable, net of unamortized debt issuance costs of 13 and 22 at march 31, 2025 and december 31, 2024, respectively
    		  14,248,000                                     
      preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at march 31, 2025 and december 31, 2024, respectively
    		  74,959,000                                     
      credit facility, net of unamortized debt issuance costs of 4,868 and 7,067 at december 31, 2024 and december 31, 2023, respectively
    		   631,732,000                                    
      notes payable, net of unamortized debt issuance costs of 22 and 66 at december 31, 2024 and december 31, 2023, respectively
    		   14,399,000                                    
      preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at december 31, 2024 and december 31, 2023, respectively
    		   74,959,000                                    
      credit facility, net of unamortized debt issuance costs of 5,418 and 7,067 at september 30, 2024 and december 31, 2023, respectively
    		    614,382,000                                   
      notes payable, net of unamortized debt issuance costs of 31 and 66 at september 30, 2024 and december 31, 2023, respectively
    		    14,493,000                                   
      preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at september 30, 2024 and december 31, 2023, respectively
    		    74,959,000                                   
      credit facility, net of unamortized debt issuance costs of 5,968 and 7,067 at june 30, 2024 and december 31, 2023, respectively
    		     599,032,000                                  
      notes payable, net of unamortized debt issuance costs of 40 and 66 at june 30, 2024 and december 31, 2023, respectively
    		     14,638,000                                  
      preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at june 30, 2024 and december 31, 2023, respectively
    		     74,959,000                                  
      credit facility, net of unamortized debt issuance costs of 6,518 and 7,067 at march 31, 2024 and december 31, 2023, respectively
    		      592,082,000                                 
      notes payable, net of unamortized debt issuance costs of 53 and 66 at march 31, 2024 and december 31, 2023, respectively
    		      25,682,000                                 
      preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at march 31, 2024 and december 31, 2023, respectively
    		      74,959,000                                 
      credit facility, net of unamortized debt issuance costs of 7,067 and 9,253 at december 31, 2023 and december 31, 2022, respectively
    		       585,333,000                                
      notes payable, net of unamortized debt issuance costs of 66 and 452 at december 31, 2023 and december 31, 2022, respectively
    		       25,899,000                                
      preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at december 31, 2023 and december 31, 2022, respectively
    		       74,959,000                                
      credit facility, net of unamortized debt issuance costs of 7,617 and 9,253 at september 30, 2023 and december 31, 2022, respectively
    		        560,783,000                               
      notes payable, net of unamortized debt issuance costs of 337 and 452 at september 30, 2023 and december 31, 2022, respectively
    		        56,823,000                               
      preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at september 30, 2023 and december 31, 2022, respectively
    		        74,959,000                               
      credit facility, net of unamortized debt issuance costs of 8,155 and 9,253 at june 30, 2023 and december 31, 2022, respectively
    		         567,988,000                              
      notes payable, net of unamortized debt issuance costs of 375 and 452 at june 30, 2023 and december 31, 2022, respectively
    		         57,121,000                              
      preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at june 30, 2023 and december 31, 2022, respectively
    		         74,959,000                              
      credit facility, net of unamortized debt issuance costs of 8,704 and 9,253 at march 31, 2023 and december 31, 2022, respectively
    		          634,796,000                             
      notes payable, net of unamortized debt issuance costs of 413 and 452 at march 31, 2023 and december 31, 2022, respectively
    		          57,367,000                             
      preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at march 31, 2023 and december 31, 2022, respectively
    		          74,959,000                             
      credit facility, net of unamortized debt issuance costs of 9,253 and 8,033 at december 31, 2022 and december 31, 2021, respectively
    		           636,447,000                            
      notes payable, net of unamortized debt issuance costs of 452 and 607 at december 31, 2022 and december 31, 2021, respectively
    		           57,672,000                            
      derivative liability
    		              1,865,000 7,790,000 12,070,000 13,814,000 14,603,000 18,086,000 19,505,000 21,495,000 20,461,000 8,685,000 10,399,000 9,083,000 5,520,000 3,487,000            
      preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at december 31, 2022 and december 31, 2021, respectively
    		           74,959,000                            
      credit facility, net of unamortized debt issuance costs of 9,802 and 8,033 at september 30, 2022 and december 31, 2021, respectively
    		            634,898,000                           
      notes payable, net of unamortized debt issuance costs of 491 and 607 at september 30, 2022 and december 31, 2021, respectively
    		            57,918,000                           
      preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at september 30, 2022 and december 31, 2021, respectively
    		            74,959,000                           
      credit facility, net of unamortized debt issuance costs of 7,113 and 8,033 at june 30, 2022 and december 31, 2021, respectively
    		             602,987,000                          
      notes payable, net of unamortized debt issuance costs of 530 and 607 at june 30, 2022 and december 31, 2021, respectively
    		             56,687,000                          
      preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at june 30, 2022 and december 31, 2021, respectively
    		             74,959,000                          
      credit facility, net of unamortized debt issuance costs of 7,570 and 8,033 at march 31, 2022 and december 31, 2021, respectively
    		              529,130,000                         
      notes payable, net of unamortized debt issuance costs of 568 and 607 at march 31, 2022 and december 31, 2021, respectively
    		              56,919,000                         
      preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at march 31, 2022 and december 31, 2021, respectively
    		              74,959,000                         
      credit facility, net of unamortized debt issuance costs of 8,033 and 3,559 at december 31, 2021 and december 31, 2020, respectively
    		               514,567,000                        
      notes payable, net of unamortized debt issuance costs of 607 and 835 at december 31, 2021 and december 31, 2020, respectively
    		               57,162,000                        
      preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at december 31, 2021 and december 31, 2020, respectively
    		               74,959,000                        
      accumulated other comprehensive loss
    		               -6,636,000 -11,946,000 -13,784,000 -14,588,000 -18,219,000 -19,651,000 -21,654,000 -20,632,000 -6,674,000 -10,596,000 -9,293,000 -5,743,000 -3,721,000 -109,000           
      credit facility, net of unamortized debt issuance costs of 8,497 and 3,559 at september 30, 2021 and december 31, 2020, respectively
    		                497,203,000                       
      notes payable, net of unamortized debt issuance costs of 644 and 835 at september 30, 2021 and december 31, 2020, respectively
    		                57,397,000                       
      preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at september 30, 2021 and december 31, 2020, respectively
    		                74,959,000                       
      credit facility, net of unamortized debt issuance costs of 8,960 and 3,559 at june 30, 2021 and december 31, 2020, respectively
    		                 442,140,000                      
      notes payable, net of unamortized debt issuance costs of 706 and 835 at june 30, 2021 and december 31, 2020, respectively
    		                 64,620,000                      
      preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at june 30, 2021 and december 31, 2020, respectively
    		                 74,959,000                      
      credit facility, net of unamortized debt issuance costs of 3,284 and 3,559 at march 31, 2021 and december 31, 2020, respectively
    		                  420,216,000                     
      notes payable, net of unamortized debt issuance costs of 772 and 835 at march 31, 2021 and december 31, 2020, respectively
    		                  64,810,000                     
      preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at march 31, 2021 and december 31, 2020, respectively
    		                  74,959,000                     
      credit facility, net of unamortized debt issuance costs of 3,559 and 3,832 at december 31, 2020 and december 31, 2019, respectively
    		                   521,641,000                    
      notes payable, net of unamortized debt issuance costs of 835 and 667 at december 31, 2020 and december 31, 2019, respectively
    		                   64,937,000                    
      security deposits and other
    		                   4,340,000 5,571,000 5,814,000 6,546,000 6,351,000 6,362,000 5,881,000 4,122,000 4,152,000 3,928,000 5,052,000 4,912,000 2,128,000 2,206,145 2,444,842      
      due to related party
    		                     1,957,000 1,948,000 1,648,000                
      preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at december 31, 2020 and december 31, 2019, respectively
    		                   74,959,000                    
      credit facility, net of unamortized debt issuance costs of 3,875 and 3,832 at september 30, 2020 and december 31, 2019, respectively
    		                    454,325,000                   
      notes payable, net of unamortized debt issuance costs of 898 and 667 at september 30, 2020 and december 31, 2019, respectively
    		                    65,060,000                   
      other liability
    		                    3,090,000 2,417,000 2,414,000 2,405,000 2,379,000 2,371,000 2,367,000             
      preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at september 30, 2020 and december 31, 2019, respectively
    		                    74,959,000                   
      credit facility, net of unamortized debt issuance costs of 3,350 and 3,832 at june 30,2020 and december 31, 2019, respectively
    		                     415,850,000                  
      notes payable, net of unamortized debt issuance costs of 668 and 667 at june 30,2020 and december 31, 2019, respectively
    		                     50,610,000                  
      preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at june 30, 2020 and december 31, 2019, respectively
    		                     74,959,000                  
      total global medical reit inc. stockholders’ equity
    		                     427,921,000     340,220,000             
      credit facility, net of unamortized debt issuance costs of 3,607 and 3,832 at march 31, 2020 and december 31, 2019, respectively
    		                      425,843,000                 
      notes payable, net of unamortized debt issuance costs of 634 and 667 at march 31, 2020 and december 31, 2019, respectively
    		                      38,648,000                 
      preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at march 31, 2020 and december 31, 2019, respectively
    		                      74,959,000                 
      credit facility, net of unamortized debt issuance costs of 3,832 and 3,922 at december 31, 2019 and 2018, respectively
    		                       347,518,000                
      notes payable, net of unamortized debt issuance costs of 667 and 799 at december 31, 2019 and 2018, respectively
    		                       38,650,000                
      preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at december 31, 2019 and 2018, respectively
    		                       74,959,000                
      credit facility, net of unamortized discount of 3,983 and 3,922 at september 30, 2019 and december 31, 2018, respectively
    		                        363,242,000               
      notes payable, net of unamortized discount of 701 and 799 at september 30, 2019 and december 31, 2018, respectively
    		                        38,651,000               
      due to related parties
    		                        1,584,000 1,358,000 1,100,000 1,030,000 1,028,000 987,000 1,035,000 1,036,000 802,286 638,790 586,899 580,911 1,135,302 2,493,401 1,068,562 
      preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at september 30, 2019 and december 31, 2018, respectively
    		                        74,959,000               
      credit facility, net of unamortized discount of 3,784 and 3,922 at june 30, 2019 and december 31, 2018, respectively
    		                         315,691,000              
      notes payable, net of unamortized discount of 733 and 799 at june 30, 2019 and december 31, 2018, respectively
    		                         38,652,000              
      preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at june 30, 2019 and december 31, 2018, respectively
    		                         74,959,000              
      liabilities and stockholders’ equity
    		                                       
      credit facility, net of unamortized discount of 3,682 and 3,922 at march 31, 2019 and december 31, 2018, respectively
    		                          219,993,000             
      notes payable, net of unamortized discount of 766 and 799 at march 31, 2019 and december 31, 2018, respectively
    		                          38,652,000             
      stockholders’ equity:
    		                                       
      preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at march 31, 2019 and december 31, 2018, respectively
    		                          74,959,000             
      total stockholders’ equity
    		                          370,562,000 299,750,000 254,656,000 255,513,000 254,743,000         
      total liabilities and stockholders’ equity
    		                          656,690,000             
      revolving credit facility, net of unamortized discount of 3,922 and 2,750 at december 31, 2018 and 2017, respectively
    		                           276,353,000            
      notes payable, net of unamortized discount of 799 and 930 at december 31, 2018 and 2017, respectively
    		                           38,654,000            
      stockholders' equity:
    		                                       
      preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at december 31, 2018 and 2017, respectively
    		                           74,959,000            
      total liabilities and stockholders' equity
    		                           636,099,000 604,091,000 602,027,000 539,856,000 474,571,000 428,927,663 369,395,591 325,768,465 227,319,130 205,791,478 98,385,696 96,096,760 
      revolving credit facility, net of unamortized discount of 4,127 and 2,750 at september 30, 2018 and december 31, 2017, respectively
    		                            293,273,000           
      notes payable, net of unamortized discount of 832 and 930 at september 30, 2018 and december 31, 2017, respectively
    		                            38,643,000           
      preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at september 30, 2018 and december 31, 2017
    		                            74,959,000           
      deferred financing costs
    		                             2,955,000 3,105,000 2,750,000 2,977,981 2,770,144 1,570,381 927,085    
      revolving credit facility
    		                             288,350,000 229,150,000 164,900,000 126,100,000 144,500,000 128,900,000 27,700,000    
      notes payable, net of unamortized discount of 865 and 930 at june 30, 2018 and december 31, 2017, respectively
    		                             38,610,000          
      preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at june 30, 2018 and december 31, 2017
    		                             74,959,000          
      notes payable, net of unamortized discount of 898 and 930 at march 31, 2018 and december 31, 2017, respectively
    		                              38,577,000         
      preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at march 31, 2018 and december 31, 2017
    		                              74,959,000         
      notes payable, net of unamortized discount of 930 and 1,062 at december 31, 2017 and 2016, respectively
    		                               38,545,000        
      notes payable to related parties
    		                                  421,000 421,000 421,000   
      preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 and no shares issued and outstanding at december 31, 2017 and 2016, respectively
    		                               74,959,000        
      cash
    		                                6,776,501 12,033,797 8,356,599 19,671,131 81,347,992 2,574,804 507,281 
      notes payable, net of unamortized discount of 963,184 and 1,061,602 at september 30, 2017 and december 31, 2016, respectively
    		                                38,511,716       
      preferred stock, 0.001 par value, 10,000,000 shares authorized; 3,105,000 and no shares issued and outstanding at september 30, 2017 and december 31, 2016, respectively
    		                                74,959,003       
      less: accumulated depreciation
    		                                 -6,520,555 -4,669,968 -3,323,915 -2,517,532 -1,932,083 -1,388,081 
      notes payable, net of unamortized discount of 995,990 and 1,061,602 at june 30, 2017 and december 31, 2016, respectively
    		                                 38,478,910      
      preferred stock, 0.001 par value, 10,000,000 shares authorized; no shares issued and outstanding
    		                                       
      common stock 0.001 par value, 500,000,000 shares authorized at june 30, 2017 and december 31, 2016, respectively; 21,105,675 and 17,605,675 shares issued and outstanding at june 30, 2017 and december 31, 2016, respectively
    		                                 21,106      
      total stockholders' equity
    		                                 176,302,594 149,254,869 155,028,378 159,708,292 12,134,927 12,750,677 
      notes payable, net of unamortized discount of 1,028,797 and 1,061,602 at march 31, 2017 and december 31, 2016, respectively
    		                                  38,446,103     
      common stock 0.001 par value, 500,000,000 shares authorized at march 31, 2017 and december 31, 2016, respectively; 17,605,675 shares issued and outstanding at march 31, 2017 and december 31, 2016, respectively
    		                                  17,606     
      convertible debenture, due to related party
    		                                       
      notes payable, net of unamortized discount of 1,061,602 and 302,892 at december 31, 2016 and december 31, 2015, respectively
    		                                   38,413,298    
      stockholders' equity
    		                                       
      common stock 0.001 par value, 500,000,000 shares authorized at december 31, 2016 and december 31, 2015, respectively; 17,605,675 and 250,000 shares issued and outstanding at december 31, 2016 and december 31, 2015, respectively
    		                                   17,606    
      building and improvements
    		                                    113,094,766 87,040,410 87,040,410 
      accrued expenses
    		                                    416,230 3,078,078 1,568,004 
      notes payable, net of unamortized discount of 1,177,522 and 302,892 at september 30, 2016 and december 31, 2015, respectively
    		                                    39,920,275   
      common stock 0.001 par value, 500,000,000 shares authorized at september 30, 2016 and december 31, 2015, respectively; 17,605,675 and 250,000 shares issued and outstanding at september 30, 2016 and december 31, 2015, respectively
    		                                    17,606   
      convertible debenture, due to majority stockholder
    		                                     25,030,134 25,030,134 
      note payable to majority stockholder
    		                                     421,000 421,000 
      note payable to related party
    		                                     450,000 450,000 
      notes payable, net of unamortized discount of 1,240,126 and 302,892 at june 30, 2016 and december 31, 2015, respectively
    		                                     54,458,657  
      common stock 0.001 par value, 500,000,000 shares authorized at june 30, 2016 and december 31, 2015, respectively; 1,426,656 and 250,000 shares issued and outstanding at june 30, 2016 and december 31, 2015, respectively
    		                                     1,427  
      prepaid assets
    		                                      27,925 
      notes payable, net of unamortized discount of 1,302,730 and 302,892, respectively
    		                                      54,488,884 
      preferred stock, 0.001 par value, 100,000,000 shares authorized; no shares issued and outstanding
    		                                       
      common stock 0.001 par value, 500,000,000 shares authorized at march 31, 2016 and december 31, 2015, respectively; 1,426,656 and 250,000 shares issued and outstanding at march 31, 2016 and december 31, 2015, respectively
    		                                      1,427 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.